View Older Stories View More Recent Stories

Apr 20, 2021 08:30AM Code Biotherapeutics Launches with $10 Million in Seed Financing to Develop Therapies for Debilitating Genetic Diseases
Apr 14, 2021 04:05PM Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Apr 14, 2021 04:05PM Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Apr 14, 2021 08:35AM OrphoMed’s ORP-101 Passes Second Planned Interim Analysis in Phase 2 Study of Treatment for IBS-D Patients
Apr 14, 2021 06:03AM Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P.
Apr 13, 2021 10:06AM Form SC 13D/A Millendo Therapeutics, Filed by: New Enterprise Associates 15, L.P.
Apr 13, 2021 09:00AM Beyond Identity Integration With Auth0 Enables Completely Passwordless Authentication
Apr 13, 2021 09:00AM Beyond Identity Integration With Auth0 Enables Completely Passwordless Authentication
Apr 13, 2021 08:30AM Strive Health Partners With NextGate to Support Whole-Patient Kidney Care
Apr 13, 2021 06:00AM Axiado Secures Initial Closing of $20M Series B Investment
Apr 12, 2021 08:00AM ICER to Use Aetion Observational RWE to Update Value Assessment of Treatments for Hereditary Angioedema
Apr 9, 2021 01:46PM Sanofi (SNY) Acquires Tidal Therapeutics for $160M Upfront and Up to $310M in Milestones
Apr 9, 2021 01:45PM Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
Apr 9, 2021 01:45PM Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
Apr 8, 2021 03:05PM Google-backed TAE Technologies raises $280 million from new, existing investors
Apr 7, 2021 11:16AM CIT GAP Funds Invests in Floorwire to Give Commercial Owners Control of Architectural Data
Apr 7, 2021 08:30AM Patreon Fuels the Future of the Creator Economy with $155 Million in Additional Funding
Apr 7, 2021 12:43AM Creators' platform Patreon valued $4 billion in latest funding round
Apr 6, 2021 12:00PM OmniSci Announces Multiple Opportunities To Accelerate Geospatial, GPU Database Knowledge At GTC 2021, April 12-16
Apr 6, 2021 09:00AM Announcing Zero Trust Authentication for Managed Devices and BYOD
Apr 6, 2021 09:00AM Announcing Zero Trust Authentication for Managed Devices and BYOD
Apr 6, 2021 07:45AM ThreatQuotient Closes $22.5 Million in New Financing to Accelerate Innovation and Execution
Apr 5, 2021 09:02AM Long Hill Capital Closes On $300M for Third Fund to Invest in Healthcare and Longevity Sectors in China
Mar 30, 2021 08:15AM New Wave Foods® Launches Its Plant-Based Shrimp to Foodservice Companies throughout the U.S.
Mar 26, 2021 10:38AM Form SC 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Mar 25, 2021 05:00PM Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
Mar 24, 2021 10:28AM CIT GAP Funds Invests in Linebird to Bring the Unmanned Systems Revolution to High Voltage Power Lines
Mar 23, 2021 04:53PM Robinhood, at the heart of retail trading frenzy, files for own IPO
Mar 23, 2021 10:45AM Study Shows New Relational Digital Therapeutic Significantly Reduced Problematic Substance Use During Pandemic
Mar 22, 2021 09:51PM 5th Stanford Drug Discovery Symposium (SDDS 2021) held virtually this year! April 19 - 20, 2021. Free registration!
Mar 20, 2021 11:00AM Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Mar 20, 2021 11:00AM Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Mar 18, 2021 01:00PM Oppenheimer & Co. Inc. Successfully Concludes 31st Annual Healthcare Conference
Mar 16, 2021 03:25PM Lumos Pharma Inc. (NASDAQ: LUMO) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
Mar 16, 2021 11:37AM CIT GAP Funds Invests in AtWork Systems to Support SMBs with Solutions for Streamlined Business Operations
Mar 16, 2021 08:02AM Strive Health Raises $140 Million Led by Alphabet’s CapitalG to Tackle $410 Billion of Unmanaged Kidney Disease Spend
Mar 12, 2021 07:00AM Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform
Mar 11, 2021 04:05PM Lumos Pharma to Participate in March 2021 Investor Conferences
Mar 11, 2021 04:05PM Lumos Pharma to Participate in March 2021 Investor Conferences
Mar 11, 2021 08:30AM CIT GAP Funds Makes Follow-On Investment in RoundlyX to Help Users Better Manage Digital Asset Portfolios
Mar 11, 2021 06:05AM Form SC 13D/A TREVENA INC Filed by: New Enterprise Associates 12, Limited Partnership
Mar 11, 2021 06:03AM Form SC 13D/A Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
Mar 11, 2021 06:03AM Form SC 13D/A DZS INC. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Mar 11, 2021 06:03AM Form SC 13D/A Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P.
Mar 11, 2021 06:03AM Form SC 13D/A Viracta Therapeutics, Filed by: New Enterprise Associates 12, Limited Partnership
Mar 9, 2021 04:07PM Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates
Mar 9, 2021 04:05PM Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Mar 9, 2021 04:05PM Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Mar 8, 2021 06:16AM Quantum Computing Company IonQ to Merge with SPAC dMY Technology Group, Inc. III (DMYI)
Mar 8, 2021 06:00AM IonQ To Become The First Publicly Traded Pure-Play Quantum Computing Company
View More Recent Stories View Older Stories